Combination treatment inhibited autophagic flux by preventing Vps34/Beclin 1 complex formation and downregulating prenylated Rab7, an active form of the small GTPase necessary for autophagosome–lysosome fusion in triple-negative breast cancer cells. Here, BECN1 is linked to triple-negative breast carcinoma.